Lv7
4568 积分 2020-12-16 加入
XmAb®5574, An Fc Engineered Humanized Anti-CD19 Monoclonal Antibody, Has Potent in Vitro and in Vivo Activities, and Has the Potential for Treating B Cell Malignancies
14小时前
求助中
PIT565, a First-in-Class Anti-CD19, Anti-CD3, Anti-CD2 Trispecific Antibody for the Treatment of B Cell Malignancies
14小时前
已完结
XmAb®5574, An Fc Engineered Humanized Anti-CD19 Monoclonal Antibody, Has Potent in Vitro and in Vivo Activities, and Has the Potential for Treating B Cell Malignancies
1天前
已关闭
HIV immune evasin Nef enhances allogeneic CAR T cell potency
13天前
已完结
Metabolic engineering for optimized CAR-T cell therapy
3个月前
已完结
Adoptive T cell therapy of solid tumors: time to team up with immunogenic chemo/radiotherapy
3个月前
已完结
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
3个月前
已完结
纳米生物学的研究现状与关键科学问题
3个月前
已完结
Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS
3个月前
已完结
SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction
4个月前
已完结
皖公网安备34019202002308
